SAWT BEIRUT INTERNATIONAL

| 7 May 2021, Friday | النسخة العربية

U.S. probing two new blood clot cases after J&J’s COVID-19 vaccine

Two new cases of blood clots after administration of Johnson & Johnson’s single-dose coronavirus vaccine are being probed by federal health officials, the U.S. Centers for Disease Control and Prevention said on Tuesday.

According to the agency, one case was in a male and the other was in a female, both of whom were below 60 years, taking the total number of confirmed such cases to 17 out of 8 million jabs administered.

The new cases come after U.S. health regulators on Friday recommended resumption of use of J&J’s dose, ending a 10-day pause to probe its link to extremely rare but potentially deadly blood clots.

The CDC and the Food and Drug Administration announced on Friday that the risks of experiencing the syndrome involving severe blood clots and low platelets as a result of the vaccine were very low.